Iksung Cho - Researcher Profile | RDL Research Database

Publications

2 shown

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech , Gary Albert , Iksung Cho +26 more

At 35 days, NVX-CoV2373 appeared to be safe, and it elicited immune responses that exceeded levels in Covid-19 convalescent serum. The Matrix-M1 adjuvant induced CD4+ T-cell res...

2020 New England Journal of Medicine 1219 citations

Prognostic value of coronary computed tomographic angiography findings in asymptomatic individuals: a 6-year follow-up from the prospective multicentre international CONFIRM study

Iksung Cho , Subhi J. Al’Aref , Adam Berger +29 more

Coronary computed tomographic angiography improved prognostication of 6-year all-cause mortality beyond a set of conventional RF alone, although, no further incremental value wa...

2017 European Heart Journal 130 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 1,349
Institution: Baylor College of Medicine

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5927-5410

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.